Recent news headlines have suggested that the federal government’s move to reclassify marijuana represents a major shift in how cannabis is treated nationwide. For many security clearance holders and applicants, the natural question is whether this change makes marijuana use less risky from a security clearance perspective.
The short answer is: no
After more than 25 years representing security clearance holders and applicants, I have seen similar policy shifts generate confusion. While the recent executive order by the President and this week’s Department of Justice action reclassifying certain marijuana products from Schedule I to Schedule III are significant in some respects, their practical impact on security clearance cases is far more limited than many assume.
What the New Policy Actually Does
The recent action reclassifies certain state-licensed and FDA-approved marijuana products as Schedule III substances, a lower-risk category under federal drug laws.
This change is intended primarily to:
- Expand medical research
- Ease regulatory burdens on certain cannabis-related activities
- Align federal policy more closely with state medical marijuana programs
However, and this is important, the change does not legalize marijuana at the federal level, particularly for recreational use.
Security Clearances Still Follow Federal Standards
Security clearance eligibility is governed by federal law and adjudicative guidelines, not by state law or public opinion.
Even with reclassification:
- Marijuana remains illegal for non-medical use under federal law
- Clearance decisions will continue to be evaluated under Guideline H (Drug Involvement) and Guideline E, Personal Conduct
- Federal workplace policies, including drug-free workplace requirements, remain in effect
As a result, marijuana use can still raise concerns about judgment, reliability, and willingness to comply with federal law, key factors in clearance adjudications. This issue will continue to affect government contractors and federal employees equally under the new policy.
Why This Likely Won’t Change Clearance Outcomes
From a practical standpoint, the reclassification does not significantly alter how clearance cases are evaluated.
Adjudicators have always focused on:
- Recency of use
- Frequency and pattern of behavior
- Intent to continue using marijuana or other drugs
- Overall compliance with federal law
Those factors remain unchanged.
Even prior guidance has made clear that a change in classification does not create a “green light” for clearance holders to use marijuana.
If the President were to issue an executive order amending Security Executive Agent Directive 4 (SEAD 4) to exclude marijuana use, that could change this equation. However, that has not occurred or been proposed as of yet.
A Common Misconception
Many individuals assume that because marijuana is now treated as a less dangerous substance or is legal in many states, it is no longer a serious clearance issue.
That assumption can result in the loss of a security clearance.
The clearance process does not operate on a sliding scale of social acceptance. It operates on the basis of risk analysis in the context of national security. As long as marijuana use conflicts with federal law or agency policy, it will continue to be scrutinized and serve as a potential basis for denial.
A Practical Hypothetical
Consider a clearance holder who decides to use marijuana occasionally following the reclassification announcement, believing the legal risk has been reduced.
If that use is later disclosed or discovered, it will still likely be evaluated under Guideline H as a security concern. The key questions will remain:
- Did the individual knowingly violate federal law or policy?
- Is the behavior ongoing?
- Does it raise concerns about judgment or reliability?
- Did the use occur while the individual was a security clearance holder?
The reclassification itself does little to mitigate those concerns.
What This Means for Security Clearance Holders
For security clearance holders, the takeaway is straightforward: the legal framework governing clearance cases has not materially changed.
We can expect:
- Continued scrutiny of marijuana use in clearance cases
- Ongoing emphasis on abstinence, particularly for current clearance holders
- Persistent confusion among clients due to mixed messaging in the media
As a result, advising clients will still require a careful explanation of the distinction between policy shifts and clearance standards.
Final Thoughts
The recent reclassification of marijuana is a meaningful development in federal drug policy, but it is not a fundamental shift in how security clearance cases are adjudicated.
Clearance holders and applicants should not assume that evolving public policy reduces the risk associated with marijuana use. Until federal law and agency-specific policies change more substantially, marijuana remains a significant clearance concern.
Understanding that distinction, and acting accordingly, remains critical to protecting both a clearance and a career.
This article is for informational purposes only and should not be construed as legal advice. Security clearance rules, federal drug policy, and agency-specific guidance may change, and readers should consult counsel regarding their specific circumstances.
